Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Respiratory and Critical Care Medicine|October 12, 2010
Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosisCamille Taillé, Sabine Grootenboer-Mignot, Céline Boursier, et al.
Frontiers in Immunology|April 30, 2024
Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature reviewLoraine Combemale, Gérôme Bohelay, Ishaï-Yaacov Sitbon, et al.
Frontiers in Immunology|July 18, 2022
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 PatientsGérôme Bohelay, Marina Alexandre, Christelle Le Roux-Villet, et al.
Seminars in Arthritis and Rheumatism|December 2, 2017
Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 casesTullia de Risi-Pugliese, Fleur Cohen Aubart, Julien Haroche, et al.
British Journal of Clinical Pharmacology|December 5, 2018
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 casesBethsabée Garel, Saskia Ingen-Housz-Oro, Daniele Afriat, et al.
British Journal of Haematology|May 23, 2023
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman diseaseYannick Dieudonné, Marc-Antoine Silvestrini, Antoine Dossier, et al.
The European Respiratory Journal|April 20, 2023
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosisKaterina Koether, Valérie Besnard, Hilary Sandig, et al.
The British Journal of Dermatology|October 4, 2023
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patientsRéda Chebani, Florian Lombart, Guillaume Chaby, et al.
Pageof 2